2008 Spring - Open Innovation, Microfluidics, et al

Open Innovation

• Open Innovation Educational Session  – Susie Stephens, Lilly
• Open pharma Innovation and the Commons – John Willbanks
• IMI – Jackie Hunter, GSK

Microfluidics

• Session Anstract – Tom Flores, GSK
• Introduction – Brian Warrington
• Continuation – Brian Warrington
• Andy Vintner

 Optimising IT cost to enhance strategic Investment

• Session Abstract – Howard Anderson, Merck
• Questionnaire

Virtualisation

• Session Abstract – Ron Behling, BMS
• Virtualisation Presentations